Evidence map›Paper›PMID 30445539›Full record

ReviewNeuro-oncology2018

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Quinn T Ostrom, Haley Gittleman, Gabrielle Truitt, Alexander Boscia, Carol Kruchko, Jill S Barnholtz-Sloan

Erratum issued Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04792437 (Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data), which is not on this map. Cited by 1,231 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,231citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04792437 unknown statusnot on this mapstarted 2021, after this paper: background citation

Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data

TypeobservationalSponsorYu Yao, MDRan2021 to 2022Enrolled120ConditionsTranscriptomics, Radiomics, GliomaArmssurgery
3 · Its place in the literature

Who cites it

1,231 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Trial
  9. Article
  10. Article
  11. Local delivery of interferon restores antigen presentation and sensitizes medulloblastoma to T cell killing.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Review
  19. Article
  20. Review

1,171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Quinn T OstromCentral Brain Tumor Registry of the United States, Hinsdale, IL, USA.
Haley GittlemanCentral Brain Tumor Registry of the United States, Hinsdale, IL, USA.
Gabrielle TruittCentral Brain Tumor Registry of the United States, Hinsdale, IL, USA.
Alexander BosciaCentral Brain Tumor Registry of the United States, Hinsdale, IL, USA.
Carol KruchkoCentral Brain Tumor Registry of the United States, Hinsdale, IL, USA.
Jill S Barnholtz-SloanCentral Brain Tumor Registry of the United States, Hinsdale, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentBrainBrain NeoplasmsCentral Nervous System NeoplasmsHumansIncidenceRegistriesUnited States

Identifiers

PMID30445539
PMCPMC6129949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.